Gainers
- Onconetix ONCO stock rose 161.5% to $0.39 during Thursday's regular session. The market value of their outstanding shares is at $8.5 million.
- Processa Pharma PCSA shares moved upwards by 98.04% to $4.06. The market value of their outstanding shares is at $5.0 million.
- Acutus Medical AFIB stock increased by 49.27% to $0.33. The market value of their outstanding shares is at $9.7 million.
- Vera Therapeutics VERA shares increased by 39.04% to $23.66. The market value of their outstanding shares is at $1.0 billion.
- Inhibikase Therapeutics IKT stock increased by 24.32% to $3.68. The company's market cap stands at $22.7 million.
- Mira Pharmaceuticals MIRA shares rose 24.21% to $1.18. The company's market cap stands at $17.4 million.
Losers
- Redhill Biopharma RDHL stock decreased by 47.6% to $0.57 during Thursday's regular session. The company's market cap stands at $11.1 million.
- Nuwellis NUWE shares fell 15.2% to $0.46. The market value of their outstanding shares is at $2.6 million.
- Immix Biopharma IMMX stock declined by 14.53% to $4.0. The company's market cap stands at $79.4 million.
- GeneDx Hldgs WGS stock fell 13.65% to $2.91. The company's market cap stands at $75.3 million.
- Concord Medical Services CCM stock declined by 12.39% to $0.81. The company's market cap stands at $35.1 million.
- Humana HUM stock declined by 12.06% to $353.89. The company's market cap stands at $43.5 billion. The company's, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CCMConcord Medical Services Holdings Ltd
$4.9910.9%
HUMHumana Inc
$255.52-0.09%
IKTInhibikase Therapeutics Inc
$2.87-3.04%
IMMXImmix Biopharma Inc
$2.05-5.96%
MIRAMira Pharmaceuticals Inc
$1.093.77%
NUWENuwellis Inc
$1.114.72%
ONCOOnconetix Inc
$0.3350-4.01%
PCSAProcessa Pharmaceuticals Inc
$0.84030.37%
RDHLRedhill Biopharma Ltd
$6.32-%
VERAVera Therapeutics Inc
$41.92-0.92%
WGSGeneDx Holdings Corp
$77.401.31%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in